Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB
WHITEHEAD INSTITUTE FOR
BIOMEDICAL RESEARCH, ORDER DENYING DEFENDANT’S
MOTION FOR ATTORNEY’S FEES Plaintiffs,
14 v. [Doc. No. 396.]
SHORELINE BIOSCIENCES, INC.,
Defendant. 17 On September 14, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a motion for attorney’s fees. (Doc. No. 396.) On October 2, 2023, the Court took the matter under submission. (Doc. No. 409.) On October 2, 2023, Plaintiffs Fate Therapeutics, Inc. (“Fate”) and Whitehead Institute for Biomedical Research (“Whitehead”) filed a response in opposition to Shoreline’s motion. (Doc. No. 413.) On October 6, 2023, Shoreline filed a reply. (Doc. No. 423.) For the reasons below, the Court denies Shoreline’s motion for attorney’s fees. Background In this action, Plaintiffs asserted claims…